A noncanonical AR addiction drives enzalutamide resistance in prostate cancer.
He Y, Wei T, Ye Z, Orme JJ, Lin D, Sheng H, Fazli L, Jeffrey Karnes R, Jimenez R, Wang L, Wang L, Gleave ME, Wang Y, Shi L, Huang H.
He Y, et al. Among authors: fazli l.
Nat Commun. 2021 Mar 9;12(1):1521. doi: 10.1038/s41467-021-21860-7.
Nat Commun. 2021.
PMID: 33750801
Free PMC article.